ICD-10-PCS Tabular Index · Section 0 · FY 2027 080

080 Alteration - Eye ICD-10-PCS

The 080 code range contains 49 ICD-10-PCS codes for Alteration procedures on the eye. 48 of the codes are billable and valid for inpatient claim submission in fiscal year 2027.

✓ Built from the official CMS FY 2027 datasetEffective Oct 1, 2026 – Sep 30, 2027
49
Procedure Codes
48
Billable Codes
080
Characters 1–3
08
Parent Body System

Root Operation Definition

Alteration: Modifying the anatomic structure of a body part without affecting the function of the body part.

ICD-10-PCS

Codes in the 080 Range 49 codes · 48 billable

49 of 49 shown
  • 080 Eye, AlterationNon-billable header
  • 080N07Z Alteration of Right Upper Eyelid with Autologous Tissue Substitute, Open Approach
  • 080N0JZ Alteration of Right Upper Eyelid with Synthetic Substitute, Open Approach
  • 080N0KZ Alteration of Right Upper Eyelid with Nonautologous Tissue Substitute, Open Approach
  • 080N0ZZ Alteration of Right Upper Eyelid, Open Approach
  • 080N37Z Alteration of Right Upper Eyelid with Autologous Tissue Substitute, Percutaneous Approach
  • 080N3JZ Alteration of Right Upper Eyelid with Synthetic Substitute, Percutaneous Approach
  • 080N3KZ Alteration of Right Upper Eyelid with Nonautologous Tissue Substitute, Percutaneous Approach
  • 080N3ZZ Alteration of Right Upper Eyelid, Percutaneous Approach
  • 080NX7Z Alteration of Right Upper Eyelid with Autologous Tissue Substitute, External Approach
  • 080NXJZ Alteration of Right Upper Eyelid with Synthetic Substitute, External Approach
  • 080NXKZ Alteration of Right Upper Eyelid with Nonautologous Tissue Substitute, External Approach
  • 080NXZZ Alteration of Right Upper Eyelid, External Approach
  • 080P07Z Alteration of Left Upper Eyelid with Autologous Tissue Substitute, Open Approach
  • 080P0JZ Alteration of Left Upper Eyelid with Synthetic Substitute, Open Approach
  • 080P0KZ Alteration of Left Upper Eyelid with Nonautologous Tissue Substitute, Open Approach
  • 080P0ZZ Alteration of Left Upper Eyelid, Open Approach
  • 080P37Z Alteration of Left Upper Eyelid with Autologous Tissue Substitute, Percutaneous Approach
  • 080P3JZ Alteration of Left Upper Eyelid with Synthetic Substitute, Percutaneous Approach
  • 080P3KZ Alteration of Left Upper Eyelid with Nonautologous Tissue Substitute, Percutaneous Approach
  • 080P3ZZ Alteration of Left Upper Eyelid, Percutaneous Approach
  • 080PX7Z Alteration of Left Upper Eyelid with Autologous Tissue Substitute, External Approach
  • 080PXJZ Alteration of Left Upper Eyelid with Synthetic Substitute, External Approach
  • 080PXKZ Alteration of Left Upper Eyelid with Nonautologous Tissue Substitute, External Approach
  • 080PXZZ Alteration of Left Upper Eyelid, External Approach
  • 080Q07Z Alteration of Right Lower Eyelid with Autologous Tissue Substitute, Open Approach
  • 080Q0JZ Alteration of Right Lower Eyelid with Synthetic Substitute, Open Approach
  • 080Q0KZ Alteration of Right Lower Eyelid with Nonautologous Tissue Substitute, Open Approach
  • 080Q0ZZ Alteration of Right Lower Eyelid, Open Approach
  • 080Q37Z Alteration of Right Lower Eyelid with Autologous Tissue Substitute, Percutaneous Approach
  • 080Q3JZ Alteration of Right Lower Eyelid with Synthetic Substitute, Percutaneous Approach
  • 080Q3KZ Alteration of Right Lower Eyelid with Nonautologous Tissue Substitute, Percutaneous Approach
  • 080Q3ZZ Alteration of Right Lower Eyelid, Percutaneous Approach
  • 080QX7Z Alteration of Right Lower Eyelid with Autologous Tissue Substitute, External Approach
  • 080QXJZ Alteration of Right Lower Eyelid with Synthetic Substitute, External Approach
  • 080QXKZ Alteration of Right Lower Eyelid with Nonautologous Tissue Substitute, External Approach
  • 080QXZZ Alteration of Right Lower Eyelid, External Approach
  • 080R07Z Alteration of Left Lower Eyelid with Autologous Tissue Substitute, Open Approach
  • 080R0JZ Alteration of Left Lower Eyelid with Synthetic Substitute, Open Approach
  • 080R0KZ Alteration of Left Lower Eyelid with Nonautologous Tissue Substitute, Open Approach
  • 080R0ZZ Alteration of Left Lower Eyelid, Open Approach
  • 080R37Z Alteration of Left Lower Eyelid with Autologous Tissue Substitute, Percutaneous Approach
  • 080R3JZ Alteration of Left Lower Eyelid with Synthetic Substitute, Percutaneous Approach
  • 080R3KZ Alteration of Left Lower Eyelid with Nonautologous Tissue Substitute, Percutaneous Approach
  • 080R3ZZ Alteration of Left Lower Eyelid, Percutaneous Approach
  • 080RX7Z Alteration of Left Lower Eyelid with Autologous Tissue Substitute, External Approach
  • 080RXJZ Alteration of Left Lower Eyelid with Synthetic Substitute, External Approach
  • 080RXKZ Alteration of Left Lower Eyelid with Nonautologous Tissue Substitute, External Approach
  • 080RXZZ Alteration of Left Lower Eyelid, External Approach

About the 080 Code Range

These procedures change the structure of an upper or lower eyelid to improve appearance without affecting how the eyelid works.

The fourth character distinguishes upper from lower eyelids and right from left. The fifth distinguishes an open approach, entry through a puncture or small incision, and work directly on the surface or by external force. The sixth identifies a substitute made from the patient’s own tissue, a synthetic substitute, a nonautologous tissue substitute, or No Device. The seventh character is No Qualifier.

Questions About This Page

How many billable codes are in the 080 range?

Of the 49 codes in this range, 48 are billable and valid for inpatient claim submission from October 1, 2026 through September 30, 2027. Table header codes group them but cannot be reported on claims.

What does the 080 range classify?

The range classifies Alteration procedures, modifying the anatomic structure of a body part without affecting the function of the body part, performed on the eye. Each code adds the body part, approach, device, and qualifier in characters four through seven, and links to its own reference page.

Related References

Source: CMS FY 2027 ICD-10-PCS order file and code tables, effective October 1, 2026 through September 30, 2027.